Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses

Giornale Italiano di Dermatologia e Venereologia

Volumn 148, Issue 2, 2013, Pages 197-201

  Quaglino, P ^a   Ponti, R ^a   Novelli, M ^a   Savoia, P ^a   Fava, P ^a   Papini, M ^b   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b St Maria Hospital   (Italy)

Author keywords

Dermatitis herpetiformis; Skin diseases; T lymphocytes, regulatory

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; ATOPIC DERMATITIS; BULLOUS PEMPHIGOID; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DOWN REGULATION; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; PHOTOCHEMOTHERAPY; PSORIASIS; PYODERMA GANGRENOSUM; REGULATORY T LYMPHOCYTE; REVIEW; SCLERODERMA; TH1 CELL; TH17 CELL; UPREGULATION;

EID: 84879032201     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol 2008;20:1361-8.
2. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007;148:32-46. (Pubitemid 46365005)
3. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003;171:6323-7. (Pubitemid 37532056)
4. Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004;114:1198-208. (Pubitemid 40385287)
5. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Regulatory T cells and human disease. Clin Dev Immunol 2007;2007:89195.
6. Ilkovitch D. Role of immune-regulatory cells in skin pathology. J Leukoc Biol 2011;89:41-9.
7. Long SA, Buckner JH. CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: more than a numbers game. J Immunol 2011;187:2061-6.
8. Yun WJ, Lee DW, Chang SE, Yoon GS, Huh JR, Won CH et al. Role of CD4CD25FOXP3 Regulatory T Cells in Psoriasis. Ann Dermatol 2010;22:397-403.
9. Soler DC, McCormick TS. The dark side of regulatory T cells in psoriasis. J Invest Dermatol 2011;131:1785-6.
10. Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 2011;131:1853-60.
11. Richetta AG, Mattozzi C, Salvi M, Giancristoforo S, D'Epiro S, Milana B et al. CD4+ CD25+ T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement. Eur J Dermatol 2011;21:344-8.
12. Quaglino P, Ortoncelli M, Comessatti A, Ponti R, Novelli M, Bergallo M et al. Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 2009;219:250-8.
13. Quaglino P, Antiga E, Comessatti A, Caproni M, Nardò T, Ponti R et al. Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. Arch Dermatol Res 2012;304:639-45.
14. Rensing-Ehl A, Gaus B, Bruckner-Tuderman L, Martin SF. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid. Exp Dermatol 2007;16:13-21. (Pubitemid 44890346)
15. Sugiyama H, Matsue H, Nagasaka A, Nakamura Y, Tsukamoto K, Shibagaki N et al. CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology 2007;214:210-20. (Pubitemid 46457606)
16. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A et al. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 2010;162:1056-63.
17. Antiga E, Kretz CC, Klembt R, Massi D, Ruland V, Stumpf C et al. Characterization of regulatory T cells in patients with dermatomyositis. J Autoimmun 2010;35:342-50.
18. Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, Sykora J et al. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 2007;56:1910-20. (Pubitemid 47110390)
19. Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010;140:845-58.
20. Cianci R, Pagliari D, Landolfi R, Frosali S, Colagiovanni A, Cammarota G et al. New insights on the role of T cells in the pathogenesis of celiac disease. J Biol Regul Homeost Agents 2012;26:171-9.
21. Hmida NB, Ben Ahmed M, Moussa A, Rejeb MB, Said Y, Kourda N et al. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease? Am J Gastroenterol 2012;107:604-11.
22. Quaglino P, Comessatti A, Ponti R, Peroni A, Mola F, Fierro MT et al. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. Int J Immunopathol Pharmacol 2009;22:353-62.
23. Kmieciak M, Gowda M, Graham L, Godder K, Bear HD, Marincola FM et al. Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med 2009;7:89.
24. Möttönen M, Heikkinen J, Mustonen L, Isomäki P, Luukkainen R, Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005;140:360-7. (Pubitemid 40559165)